MedPath

The association between new and established cardiovascular serum markers.

Completed
Registration Number
NL-OMON28872
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Groups of AMI, SAP, UAP and controls will be formed (n=120). All participants will donate a venous blood sample at inclusion, and after 6 and 12 months. Marker concentration will be evaluated in these blood samples.

Exclusion Criteria

1. Unable to give informed consent;

2. CVD < 6 months;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(Recurrent) cardiovascular disease, e.g. MI, SAP, UAP, mortality.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath